Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0299
+0.0009 (3.10%)
Jun 27, 2025, 3:47 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Gene Control Medicines
9.94M
Log In
Log In
Log In
Log In
Upgrade
Gene Control Medicines Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
9.94M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade